NL8205067A - Nieuwe bicyclische verbindingen, alsmede werkwijze voor de bereiding ervan. - Google Patents
Nieuwe bicyclische verbindingen, alsmede werkwijze voor de bereiding ervan. Download PDFInfo
- Publication number
- NL8205067A NL8205067A NL8205067A NL8205067A NL8205067A NL 8205067 A NL8205067 A NL 8205067A NL 8205067 A NL8205067 A NL 8205067A NL 8205067 A NL8205067 A NL 8205067A NL 8205067 A NL8205067 A NL 8205067A
- Authority
- NL
- Netherlands
- Prior art keywords
- oxo
- methyl
- dioxolan
- group
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/18—Oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU814015A HU185491B (en) | 1981-12-30 | 1981-12-30 | Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptane derivatives |
HU401581 | 1982-12-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8205067A true NL8205067A (nl) | 1983-07-18 |
Family
ID=10966521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8205067A NL8205067A (nl) | 1981-12-30 | 1982-12-30 | Nieuwe bicyclische verbindingen, alsmede werkwijze voor de bereiding ervan. |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS58118587A (it) |
AT (1) | AT376982B (it) |
BE (1) | BE895492A (it) |
CA (1) | CA1190931A (it) |
DE (1) | DE3248676A1 (it) |
ES (1) | ES8501747A1 (it) |
FI (1) | FI824520L (it) |
FR (1) | FR2519001B1 (it) |
GB (1) | GB2114124A (it) |
GR (1) | GR77070B (it) |
HU (1) | HU185491B (it) |
IT (1) | IT1210970B (it) |
LU (1) | LU84569A1 (it) |
NL (1) | NL8205067A (it) |
PL (1) | PL239888A1 (it) |
SE (1) | SE8207478L (it) |
ZA (1) | ZA829596B (it) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5625110A (en) * | 1978-12-18 | 1981-03-10 | Bristol Myers Co | Antibacterial |
IE52147B1 (en) * | 1980-03-27 | 1987-07-08 | Merck & Co Inc | 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation |
JPS57176982A (en) * | 1981-04-24 | 1982-10-30 | Shionogi & Co Ltd | Dioxolanylazetidinone compound, its preparation and use |
-
1981
- 1981-12-30 HU HU814015A patent/HU185491B/hu not_active IP Right Cessation
-
1982
- 1982-12-10 AT AT0450882A patent/AT376982B/de not_active IP Right Cessation
- 1982-12-28 BE BE1/10679A patent/BE895492A/fr not_active IP Right Cessation
- 1982-12-28 JP JP57235158A patent/JPS58118587A/ja active Pending
- 1982-12-29 LU LU84569A patent/LU84569A1/fr unknown
- 1982-12-29 SE SE8207478A patent/SE8207478L/xx not_active Application Discontinuation
- 1982-12-29 FR FR8221975A patent/FR2519001B1/fr not_active Expired
- 1982-12-30 DE DE19823248676 patent/DE3248676A1/de not_active Withdrawn
- 1982-12-30 NL NL8205067A patent/NL8205067A/nl not_active Application Discontinuation
- 1982-12-30 CA CA000418742A patent/CA1190931A/en not_active Expired
- 1982-12-30 ZA ZA829596A patent/ZA829596B/xx unknown
- 1982-12-30 ES ES518723A patent/ES8501747A1/es not_active Expired
- 1982-12-30 PL PL23988882A patent/PL239888A1/xx unknown
- 1982-12-30 GR GR70187A patent/GR77070B/el unknown
- 1982-12-30 IT IT8225063A patent/IT1210970B/it active
- 1982-12-30 GB GB08236914A patent/GB2114124A/en not_active Withdrawn
- 1982-12-30 FI FI824520A patent/FI824520L/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
LU84569A1 (fr) | 1984-10-22 |
ATA450882A (de) | 1984-06-15 |
FR2519001A1 (fr) | 1983-07-01 |
ZA829596B (en) | 1983-10-26 |
DE3248676A1 (de) | 1983-07-07 |
ES518723A0 (es) | 1984-12-16 |
FR2519001B1 (fr) | 1985-10-25 |
GB2114124A (en) | 1983-08-17 |
GR77070B (it) | 1984-09-05 |
BE895492A (fr) | 1983-06-28 |
IT1210970B (it) | 1989-09-29 |
AT376982B (de) | 1985-01-25 |
ES8501747A1 (es) | 1984-12-16 |
JPS58118587A (ja) | 1983-07-14 |
CA1190931A (en) | 1985-07-23 |
SE8207478L (sv) | 1983-07-01 |
HU185491B (en) | 1985-02-28 |
PL239888A1 (en) | 1984-01-02 |
IT8225063A0 (it) | 1982-12-30 |
FI824520L (fi) | 1983-07-01 |
SE8207478D0 (sv) | 1982-12-29 |
FI824520A0 (fi) | 1982-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6201118B1 (en) | Process for forming an N-acylated, N,N-containing bicyclic ring from piperazic acid or an ester thereof especially useful as an intermediate in the manufacture of a caspase inhibitor | |
Miah et al. | Synthesis of the marine dibromooxoindoline convolutamydine C | |
US4122086A (en) | Isopenicillins | |
NL8205067A (nl) | Nieuwe bicyclische verbindingen, alsmede werkwijze voor de bereiding ervan. | |
Enders et al. | A highly efficient asymmetric synthesis of homotaurine derivatives via diastereoselective ring-opening of γ-sultones | |
NL8205065A (nl) | Nieuwe bicyclische verbindingen en een werkwijze voor de bereiding ervan. | |
NL8205066A (nl) | Werkwijze voor de bereiding van nieuwe bicyclische verbindingen. | |
GB1566262A (en) | 3 - amino - 4 - oxoazetidine derivatives | |
NL8205070A (nl) | Werkwijze voor de bereiding van heterocyclische azijnzuurderivaten. | |
NL8205064A (nl) | Nieuwe heterocyclische azijnzuurderivaten en werkwijze voor de bereiding ervan. | |
JP3224584B2 (ja) | 2,3−ジヒドロインドール−3,3−ジカルボン酸及び2,3−ジヒドロインドール−3−カルボン酸誘導体 | |
JPS6254310B2 (it) | ||
NL8205069A (nl) | Nieuwe heterocyclische carbonzuren en werkwijze voor de bereiding ervan. | |
HU188913B (en) | Process for producing new azetidinyl-acetic acid esters | |
IE44231B1 (en) | 3-amino-4-oxazetidine derivatives | |
GB2112772A (en) | Derivatives of azetidin-2-one | |
NL8205068A (nl) | Nieuwe heterocyclische azijnzuurderivaten, alsmede werkwijze voor de bereiding ervan. | |
BE799945A (fr) | Esters de penicillines | |
SK30498A3 (en) | Epoxy - azetidinones, the preparation and use thereof | |
IE43846B1 (en) | Azetidine compounds | |
JPH0250107B2 (it) | ||
HU183484B (en) | Process for preparing new azetidinone derivatives containing protected o-acetyl group | |
JPH0971574A (ja) | カルバミン酸テトラヒドロフリルエステル誘導体の製造方法 | |
JPS5810563A (ja) | N−置換プロリン誘導体の鏡像異性体の選択的製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |